Agenus: Agenus Stock Soars Over 100% as BATTMAN Takes a Back Seat to ROBBIN
Agenus stock surged 100%, after the biotech secured up to $340 million in fresh capital, extended its cash runway, shelving the Phase 3 BATTMAN trial while doubling down on ROBBIN.read more
Read full article »
Agenus is a Massachusetts-based biotechnology company that researches and commercializes immunotherapies for the treatment of cancer.
Read more